Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 49.04 USD -2.62%
Market Cap: 4.8B USD
Have any thoughts about
Biohaven Pharmaceutical Holding Company Ltd?
Write Note

Biohaven Pharmaceutical Holding Company Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biohaven Pharmaceutical Holding Company Ltd
Change in Working Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Change in Working Capital
$24.6m
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Change in Working Capital
-$1.9B
CAGR 3-Years
-19%
CAGR 5-Years
-7%
CAGR 10-Years
-20%
Gilead Sciences Inc
NASDAQ:GILD
Change in Working Capital
$7.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Change in Working Capital
-$612m
CAGR 3-Years
30%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Change in Working Capital
-$762.1m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Change in Working Capital
-$593.3m
CAGR 3-Years
28%
CAGR 5-Years
-7%
CAGR 10-Years
N/A

See Also

What is Biohaven Pharmaceutical Holding Company Ltd's Change in Working Capital?
Change in Working Capital
24.6m USD

Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Change in Working Capital amounts to 24.6m USD.

What is Biohaven Pharmaceutical Holding Company Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
40%

The average annual Change in Working Capital growth rates for Biohaven Pharmaceutical Holding Company Ltd have been 40% over the past three years .

Back to Top